Satellos Bioscience Inc.
MSCL
Rangering i aksjer
#17818
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Aksjekurs
$10.22
Sist synkronisert: 2026-07-31
Markedsverdi
$212.97M
Endring (1 dag)
4.58%
Endring (1 år)
2,278.10%
Land
CA
Handel Satellos Bioscience Inc. (MSCL)
Kategori
Healthcare
Historikk for aksjesplitt for Satellos Bioscience Inc. (MSCL)
Aksjen Satellos Bioscience Inc. (symbol: MSCL) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én MSCL-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 MSCL-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én MSCL-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 MSCL-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
